Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Barta

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Orvosi Hetilap|January 5, 2002
[Anti-Saccharomyces cerevisiae antibodies in patients with Crohn's disease]Z Barta, I Csípö, P Antal-Szalmás, et al.
Journal of Clinical Microbiology|November 8, 2003
Restriction enzyme analysis of ribosomal DNA shows that Candida inconspicua clinical isolates can be misidentified as Candida norvegensis with traditional diagnostic proceduresL Majoros, G Kardos, A Belák, et al.
Lupus|December 17, 2009
Health-related quality of life, smoking and carotid atherosclerosis in white British women with systemic lupus erythematosusZ Barta, M J Harrison, T Wangrangsimakul, et al.
Alimentary Pharmacology & Therapeutics|September 3, 2011
Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's diseaseL S Kiss, T Szamosi, T Molnar, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Orvosi Hetilap|January 5, 2002
[Anti-Saccharomyces cerevisiae antibodies in patients with Crohn's disease]Z Barta, I Csípö, P Antal-Szalmás, et al.
Journal of Clinical Microbiology|November 8, 2003
Restriction enzyme analysis of ribosomal DNA shows that Candida inconspicua clinical isolates can be misidentified as Candida norvegensis with traditional diagnostic proceduresL Majoros, G Kardos, A Belák, et al.
Lupus|December 17, 2009
Health-related quality of life, smoking and carotid atherosclerosis in white British women with systemic lupus erythematosusZ Barta, M J Harrison, T Wangrangsimakul, et al.
Alimentary Pharmacology & Therapeutics|September 3, 2011
Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's diseaseL S Kiss, T Szamosi, T Molnar, et al.
Pageof 2